EraGen Biosciences

EraGen Biosciences developed and commercialized high performance molecular diagnostics and drug discovery products to capitalize on the rapidly growing market for personalized medicine and rapid response needs for bioterrorism. EraGen’s approach to gene-based research helped customers, partners and collaborators drive their genetic diagnostics and drug development efforts to the patient faster. Luminex Corp. (Nasdaq: LMNX) acquired EraGen in 2011.